THEMISMED.BOTHEMISMED.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.3%
5Y CAGR+13.7%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+31.3%/yr
vs -6.7%/yr prior
5Y CAGR
+13.7%/yr
Recent acceleration
Acceleration
+38.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.05B+113.0%
2025$963.76M-14.4%
2024$1.13B+24.1%
2023$907.04M-42.0%
2022$1.56B+45.1%
2021$1.08B-1.3%
2020$1.09B-8.9%
2019$1.20B+1.1%
2018$1.19B-5.8%
2017$1.26B-